SPRO 8-K: SEC filing
Spero Therapeutics
Filed with the SEC on · accession 0001193125-26-458637
SPRO filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -2.3% by the first close after the filing.
Summary of the filing
Spero Therapeutics issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished as Exhibit 99.1 to the Form 8-K.
Key details
How SPRO stock reacted
Close before
$1.02
Nov 11, 2026
First close after
-2.27%
$1.00
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for SPRO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SPRO?
Click hereFrequently asked questions
What did SPRO file with the SEC on Nov 12, 2026?
SPRO filed a 8-K (SEC filing). Spero Therapeutics issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished as Exhibit 99.1 to the Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did SPRO stock react to this filing?
SPRO closed at $1.02 before the filing and $1.00 on Nov 12, 2026 (-2.27%).
Other SPRO SEC filings
- 8-K · Board changeNov 10, 2026
- 8-K · Executive departureOct 27, 2026
- EFFECT · SEC filingSep 10, 2026
- S-3 · Shelf registrationAug 28, 2026
- 8-K · Material agreementAug 28, 2026
- 8-K · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 12, 2026
- 8-K · Material agreementJul 14, 2026
- 8-K · SEC filingJun 25, 2026
- 8-K · Fda approvalJun 22, 2026
Get alerts when SPRO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days